Department of Biomedical Engineering, Indiana-Purdue University, Indianapolis, IN 46202, USA.
EuroIntervention. 2013 Apr 22;8(12):1461-3. doi: 10.4244/EIJV8I12A220.
Elevation of biomarkers and ischaemia after coronary stenting of a bifurcation is not uncommon due to side branch (SB) occlusion. Hence, it is important to understand the relation between the lumen calibre of the SB and the myocardial mass affected. The objective of this proof of concept perspective is to provide a formulation for the relation between the SB calibre and perfused myocardial mass based on experimentally-validated scaling laws. A lumen calibre-mass scaling law provides a nearly linear relation between cross-sectional area of SB and the myocardial mass at risk. It is clinically known that the larger the diameter of the SB the more myocardial mass is at risk. The present analysis formulates this notion quantitatively and provides a simple relation where the %infarct can be determined directly from the angiographic cross-sectional area of SB. This relation can help guide the decision for bifurcation stenting where the SB may be at risk for occlusion. This brief proof of concept perspective provides a basis for future human studies that may demarcate the calibre (and hence myocardial mass) in relation to cardiac biomarkers as a cut-off for treatment of SB.
由于边支(SB)闭塞,冠状动脉支架置入后生物标志物升高和缺血在分叉处并不少见。因此,了解 SB 管腔直径与受影响心肌质量之间的关系非常重要。本概念验证的目的是基于经过实验验证的比例定律,为 SB 口径与灌注心肌质量之间的关系提供一个公式。管腔口径-质量比例定律提供了 SB 的横截面积与风险心肌质量之间的几乎线性关系。临床已知 SB 的直径越大,风险心肌的质量就越大。本分析从定量上阐述了这一概念,并提供了一个简单的关系,其中可以直接从 SB 的血管造影横截面积确定梗死百分比。该关系可以帮助指导分叉支架置入的决策,因为 SB 可能有闭塞的风险。本简要的概念验证为未来的人类研究提供了基础,这些研究可能会根据心脏生物标志物划定 SB 的口径(因此也是心肌质量)作为治疗 SB 的截止值。